126 related articles for article (PubMed ID: 29641588)
1. Scaffold hopping from (5-hydroxymethyl) isophthalates to multisubstituted pyrimidines diminishes binding affinity to the C1 domain of protein kinase C.
Provenzani R; Tarvainen I; Brandoli G; Lempinen A; Artes S; Turku A; Jäntti MH; Talman V; Yli-Kauhaluoma J; Tuominen RK; Boije Af Gennäs G
PLoS One; 2018; 13(4):e0195668. PubMed ID: 29641588
[TBL] [Abstract][Full Text] [Related]
2. C1 domain-targeted isophthalates as protein kinase C modulators: structure-based design, structure-activity relationships and biological activities.
Talman V; Provenzani R; Boije af Gennäs G; Tuominen RK; Yli-Kauhaluoma J
Biochem Soc Trans; 2014 Dec; 42(6):1543-9. PubMed ID: 25399568
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological activity of isophthalic acid derivatives targeted to the C1 domain of protein kinase C.
Boije af Gennäs G; Talman V; Aitio O; Ekokoski E; Finel M; Tuominen RK; Yli-Kauhaluoma J
J Med Chem; 2009 Jul; 52(13):3969-81. PubMed ID: 19438240
[TBL] [Abstract][Full Text] [Related]
4. Effects of ortho substituent groups of protocatechualdehyde derivatives on binding to the C1 domain of novel protein kinase C.
Mamidi N; Borah R; Sinha N; Jana C; Manna D
J Phys Chem B; 2012 Sep; 116(35):10684-92. PubMed ID: 22861150
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and protein kinase C (PKC)-C1 domain binding properties of diacyltetrol based anionic lipids.
Mamidi N; Panda S; Borah R; Manna D
Mol Biosyst; 2014 Nov; 10(11):3002-13. PubMed ID: 25190464
[TBL] [Abstract][Full Text] [Related]
6. The C1 domain-targeted isophthalate derivative HMI-1b11 promotes neurite outgrowth and GAP-43 expression through PKCα activation in SH-SY5Y cells.
Talman V; Amadio M; Osera C; Sorvari S; Boije Af Gennäs G; Yli-Kauhaluoma J; Rossi D; Govoni S; Collina S; Ekokoski E; Tuominen RK; Pascale A
Pharmacol Res; 2013 Jul; 73():44-54. PubMed ID: 23643828
[TBL] [Abstract][Full Text] [Related]
7. C1 Domain-targeted isophthalate derivatives induce cell elongation and cell cycle arrest in HeLa cells.
Talman V; Tuominen RK; Boije af Gennäs G; Yli-Kauhaluoma J; Ekokoski E
PLoS One; 2011; 6(5):e20053. PubMed ID: 21629792
[TBL] [Abstract][Full Text] [Related]
8. Alkyl cinnamates as regulator for the C1 domain of protein kinase C isoforms.
Mamidi N; Gorai S; Sahoo J; Manna D
Chem Phys Lipids; 2012 Apr; 165(3):320-30. PubMed ID: 22414757
[TBL] [Abstract][Full Text] [Related]
9. Elucidating the interaction of γ-hydroxymethyl-γ-butyrolactone substituents with model membranes and protein kinase C-C1 domains.
Borah R; Mamidi N; Panda S; Gorai S; Pathak SK; Manna D
Mol Biosyst; 2015 May; 11(5):1389-99. PubMed ID: 25820877
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a role of MRCK in mediating HeLa cell elongation induced by the C1 domain ligand HMI-1a3.
Talman V; Gateva G; Ahti M; Ekokoski E; Lappalainen P; Tuominen RK
Eur J Pharm Sci; 2014 May; 55():46-57. PubMed ID: 24486483
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Evaluation of Dimeric Derivatives of Diacylglycerol-Lactones as Protein Kinase C Ligands.
Ohashi N; Kobayashi R; Nomura W; Kobayakawa T; Czikora A; Herold BK; Lewin NE; Blumberg PM; Tamamura H
Bioconjug Chem; 2017 Aug; 28(8):2135-2144. PubMed ID: 28671468
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the novel anthracycline antitumor agent N-benzyladriamycin-14-valerate with the C1-regulatory domain of protein kinase C: structural requirements, isoform specificity, and correlation with drug cytotoxicity.
Roaten JB; Kazanietz MG; Caloca MJ; Bertics PJ; Lothstein L; Parrill AL; Israel M; Sweatman TW
Mol Cancer Ther; 2002 May; 1(7):483-92. PubMed ID: 12479266
[TBL] [Abstract][Full Text] [Related]
13. Development of diacyltetrol lipids as activators for the C1 domain of protein kinase C.
Mamidi N; Gorai S; Mukherjee R; Manna D
Mol Biosyst; 2012 Apr; 8(4):1275-85. PubMed ID: 22301880
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and structure-activity relationship of new isobenzofuranone ligands of protein kinase C.
Baba Y; Ogoshi Y; Hirai G; Yanagisawa T; Nagamatsu K; Mayumi S; Hashimoto Y; Sodeoka M
Bioorg Med Chem Lett; 2004 Jun; 14(11):2963-7. PubMed ID: 15125969
[TBL] [Abstract][Full Text] [Related]
15. Ligand structure-activity requirements and phospholipid dependence for the binding of phorbol esters to protein kinase D.
Wang QJ; Fang TW; Yang D; Lewin NE; Van Lint J; Marquez VE; Blumberg PM
Mol Pharmacol; 2003 Dec; 64(6):1342-8. PubMed ID: 14645664
[TBL] [Abstract][Full Text] [Related]
16. Selective binding of phorbol esters and diacylglycerol by individual C1 domains of the PKD family.
Chen J; Deng F; Li J; Wang QJ
Biochem J; 2008 Apr; 411(2):333-42. PubMed ID: 18076381
[TBL] [Abstract][Full Text] [Related]
17. Toward the development of new medicinal leads with selectivity for protein kinase C isozymes.
Irie K; Nakagawa Y; Ohigashi H
Chem Rec; 2005; 5(4):185-95. PubMed ID: 16041745
[TBL] [Abstract][Full Text] [Related]
18. Design and physicochemical properties of new fluorescent ligands of protein kinase C isozymes focused on CH/pi interaction.
Sugimoto T; Itagaki K; Irie K
Bioorg Med Chem; 2008 Jan; 16(2):650-7. PubMed ID: 17977729
[TBL] [Abstract][Full Text] [Related]
19. Differential roles of the tandem C1 domains of protein kinase C delta in the biphasic down-regulation induced by bryostatin 1.
Lorenzo PS; Bögi K; Hughes KM; Beheshti M; Bhattacharyya D; Garfield SH; Pettit GR; Blumberg PM
Cancer Res; 1999 Dec; 59(24):6137-44. PubMed ID: 10626804
[TBL] [Abstract][Full Text] [Related]
20. Contribution of the C1A and C1B domains to the membrane interaction of protein kinase C.
Giorgione J; Hysell M; Harvey DF; Newton AC
Biochemistry; 2003 Sep; 42(38):11194-202. PubMed ID: 14503869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
